These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22082707)

  • 1. Implantable cardioverter/defibrillators in the primary prevention of sudden death: we know what to do but are we doing it?
    Hauptman PJ
    Arch Intern Med; 2012 Jan; 172(1):67-8. PubMed ID: 22082707
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.
    Miller AL; Wang Y; Curtis J; Masoudi FA; Buxton AE; Wang TY
    Arch Intern Med; 2012 Jan; 172(1):64-7. PubMed ID: 22082711
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for implantation of primary prevention defibrillators: who is listening?
    Markowitz SM
    Heart Rhythm; 2012 Jun; 9(6):882-3. PubMed ID: 22342865
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity in primary versus secondary prevention indication implantable cardioverter defibrillator recipients 6-12 months after implantation - a cross-sectional study with register follow up.
    Berg SK; Thygesen LC; Svendsen JH; Christensen AV; Zwisler AD
    Arch Phys Med Rehabil; 2015 Mar; 96(3):426-31. PubMed ID: 25448249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Sudden Cardiac Death in Adults With Congenital Heart Disease: Do the Guidelines Fall Short?
    Vehmeijer JT; Koyak Z; Budts W; Harris L; Silversides CK; Oechslin EN; Bouma BJ; Zwinderman AH; Mulder BJM; de Groot JR
    Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28696220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators not for everyone. But not all physicians follow criteria for patient implantation, analysis shows.
    Duke Med Health News; 2011 Mar; 17(3):1-2. PubMed ID: 21476239
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
    Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spanish implantable cardioverter-defibrillator registry. Seventh official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2010)].
    Alzueta J; Fernández JM
    Rev Esp Cardiol; 2011 Nov; 64(11):1023-34. PubMed ID: 21967881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality and Safety in Health Care, Part XLII: Introduction to the Implantable Cardioverter Defibrillator Registry.
    Harolds JA
    Clin Nucl Med; 2018 Nov; 43(11):818-819. PubMed ID: 29939951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward more optimal use of primary prevention implantable cardioverter-defibrillators: how do we get there?
    Al-Khatib SM
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):140-2. PubMed ID: 21406668
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden cardiac death of two heart transplant patients with correctly functioning implantable cardioverter defibrillators.
    Marzoa-Rivas R; Perez-Alvarez L; Paniagua-Martin MJ; Ricoy-Martinez E; Flores-Ríos X; Rodriguez-Fernandez JA; Salgado-Fernandez J; Franco-Gutierrez R; Cuenca-Castillo JJ; Herrera JM; Capdevila A; Vazquez P; Castro-Beiras A; Crespo-Leiro MG
    J Heart Lung Transplant; 2009 Apr; 28(4):412-4. PubMed ID: 19332273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
    Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
    Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
    Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National registry data on implantable cardioverter defibrillator treatment: what are they useful for?
    Nielsen JC
    Europace; 2009 Apr; 11(4):405-6. PubMed ID: 19182233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.